McKesson Corporation MCK today announced that Brian S. Tyler, Ph.D., has been appointed president, McKesson U.S. Pharmaceutical, effective January 1, 2011.
Currently the president of McKesson Medical-Surgical, a $2.4 billion operating unit of McKesson Corp., Tyler will succeed John Figueroa, who has accepted the position of CEO of Omnicare, also effective January 1, 2011.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in